With the presence of a large pool of participants, the global Hba1c testing device market is displaying a highly competitive business landscape, finds a new research report by Zion Market Research (ZMR). Danaher Corporation, Siemens Healthcare, Bio-Rad Laboratories Incorporation, Abbott Laboratories, F. Hoffmann-La Roche Ltd, and Alere Incorporation are few of the vendors aggressively on innovation, as well as on including advanced technologies in their existing products. Over the coming years, they are also expected to take up partnerships and mergers and acquisitions as their key strategy for business development, states the Hba1c testing device market study.
Reportedly, on 20th August 2018, National Institutes of Health conducted the study and revealed that blood test carried out during the tenth week of pregnancy can assist in identifying the risks related to gestational diabetes occurrence.
As estimated in this report, the global Hba1c testing device market stood at US$ 1.20 billion in 2015. Witnessing a tremendous rise during the period from 2015 to 2021, the revenue in this Hba1c testing device market is expected to reach US$ 2.20 billion by the end of the forecast period. The main products available in this Hba1c testing device market are handheld devices and bench-top devices. Among them, the demand for bench-top HbA1c testing device is relatively higher and the trend is anticipated to remain so over the next few years, notes the research report.
Request Free Sample Research Report @ https://www.zionmarketresearch.com/sample/hba1c-testing-device-market
Rapid Rise In Diabetic Patient Population Base To Propel Market Expansion
“Steep rise in population of diabetics along with prominent cases of diabetes witnessed across the countries having low-income & middle-income population is predicted to propel the demand for Hba1c testing,” says the author of this Hba1c testing device market study. Apart from this, increase in the awareness levels pertaining to preventive care and diabetes management will further drive the growth of Hba1c testing device market in the years ahead. Introduction of new technologies for measuring HbA1c will further contribute towards the HbA1C testing device market revenue over the ensuing years.
Escalating product costs and lack of accuracy in the derived outcomes observed from clinical tests performed on pregnant women, old persons, and non-Hispanic black population, is anticipated to obstruct the Hba1c testing device market progression in the near future. Nevertheless, unexplored market potential and global popularity of medical tourism is projected to provide lucrative opportunities for the industry growth in the coming years, thereby normalizing the impact of hindrances on the Hba1c testing device market, reports the Hba1c testing device market study.
Inquire more about this report @ https://www.zionmarketresearch.com/inquiry/hba1c-testing-device-market
Presence of Well-Established Healthcare Infrastructure To Assist North American Regional Dominance
Regionally, North America has been leading the worldwide Hba1c testing device market and is anticipated to continue on the dominant position in the years to come, states the Hba1c testing device market study. The presence of a well-established healthcare infrastructure and growing incidences of diabetes mellitus witnessed in the region is the main factor behind the dominance of the North America Hba1c testing device market.